These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38536042)

  • 21. Cystic Fibrosis Liver Disease: Know More.
    Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R
    Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystic fibrosis liver disease in Newfoundland and Labrador: a prevalence study.
    Squirell E; Lockyer J
    Can Liver J; 2021; 4(1):33-37. PubMed ID: 35991469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.
    Boëlle PY; Debray D; Guillot L; Clement A; Corvol H;
    Hepatology; 2019 Apr; 69(4):1648-1656. PubMed ID: 30058245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis.
    Cook NL; Pereira TN; Lewindon PJ; Shepherd RW; Ramm GA
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):247-54. PubMed ID: 25625579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis.
    Calvopina DA; Noble C; Weis A; Hartel GF; Ramm LE; Balouch F; Fernandez-Rojo MA; Coleman MA; Lewindon PJ; Ramm GA
    J Cyst Fibros; 2020 May; 19(3):449-454. PubMed ID: 31303380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 Patients.
    Zhou YH; Gallins PJ; Pace RG; Dang H; Aksit MA; Blue EE; Buckingham KJ; Collaco JM; Faino AV; Gordon WW; Hetrick KN; Ling H; Liu W; Onchiri FM; Pagel K; Pugh EW; Raraigh KS; Rosenfeld M; Sun Q; Wen J; Li Y; Corvol H; Strug LJ; Bamshad MJ; Blackman SM; Cutting GR; Gibson RL; O'Neal WK; Wright FA; Knowles MR
    Am J Respir Crit Care Med; 2023 May; 207(10):1324-1333. PubMed ID: 36921087
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease.
    Rath T; Hage L; Kügler M; Menendez Menendez K; Zachoval R; Naehrlich L; Schulz R; Roderfeld M; Roeb E
    PLoS One; 2013; 8(3):e58955. PubMed ID: 23516586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of a cross-sectional ultrasound- based study of cystic fibrosis related liver disease: A real world experience.
    Kurkal K; Kuek SL; Herath D; Ong C; Harrison J; Cooney H; Poulter C; Oliver M
    J Cyst Fibros; 2024 Jun; ():. PubMed ID: 38942721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis.
    Nash EF; Volling C; Gutierrez CA; Tullis E; Coonar A; McRae K; Keshavjee S; Singer LG; Durie PR; Chaparro C
    Clin Transplant; 2012; 26(1):34-41. PubMed ID: 21272072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools.
    Scott JA; Jones AM; Jokl E; Gordon-Walker T; Barry PJ; Hanley NA; Piper Hanley K; Athwal VS
    Heliyon; 2023 Nov; 9(11):e21861. PubMed ID: 38053913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study.
    Baldissera M; Lewindon PJ; Ramm LE; Hartel GF; Mattiello R; Ramm GA
    J Cyst Fibros; 2022 Mar; 21(2):230-235. PubMed ID: 34949555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities.
    Singh H; Coffey MJ; Ooi CY
    J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):796-800. PubMed ID: 32443033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients.
    Kutney K; Donnola SB; Flask CA; Gubitosi-Klug R; O'Riordan M; McBennett K; Sferra TJ; Kaminski B
    World J Hepatol; 2019 Dec; 11(12):761-772. PubMed ID: 31966908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
    Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
    Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
    J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of liver disease on mortality in cystic fibrosis-A systematic review.
    Sasame A; Stokes D; Bourke B; Connolly L; Fitzpatrick E; Rowland M
    J Cyst Fibros; 2022 Mar; 21(2):202-211. PubMed ID: 34380590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis.
    Thavamani A; Umapathi KK; Kutney K; Sferra TJ; Sankararaman S
    Pediatr Pulmonol; 2022 Jul; 57(7):1717-1725. PubMed ID: 35499220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
    Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
    Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.
    Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A
    Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study.
    Poetter-Lang S; Staufer K; Baltzer P; Tamandl D; Muin D; Bastati N; Halilbasic E; Hodge JC; Trauner M; Kazemi-Shirazi L; Ba-Ssalamah A
    Eur Radiol; 2019 Feb; 29(2):1048-1058. PubMed ID: 30054796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.